- Head of Investment Research
- Insights
- Sustainability
- About Us
- Careers
- My Account
Formats
Sustainable Investing
Stewardship Principles
Investment Solutions
The views expressed are those of the authors at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
This is an excerpt from our 2023 Investment Outlook, in which specialists from across our investment platform share insights on the economic and market forces that we expect to influence portfolios in the year to come. This is a chapter in the Equity Market Outlook section.
We believe now is a time of great transition for asset allocators. With investment regime change challenging the status quo across global markets, asset classes, and sectors, should allocators be questioning many of the assumptions that have underpinned portfolio decision-making for the past two decades? We think so — at least from an equity standpoint. In our view, thematic investing can help allocators navigate this evolving landscape.
In today’s era of heightened market volatility and rampant investor “short-termism,” having conviction in compelling, long-term structural trends could prove to be a defining edge, in terms of both risk management and return generation. Macro uncertainty has triggered wild sentiment swings, resulting in market rotations along factor, sector, and country lines, with seemingly little consideration of company-by-company idiosyncrasies. In many cases, industry leaders are being discounted at the same rate as their less-innovative peers. Meanwhile, competitive moats are expanding as the cost of capital rises. Forward-looking management teams are doubling down on the multiyear trends that are impacting their business, while other firms are overly fixated on near-term profit margin protection. The market's underappreciation of these nuances is being exaggerated by compromised liquidity across global equities, amplifying the severity of both up and down market moves.
Against this backdrop, rigorous investment research, direct engagement with companies, and agile active management are likely to be even more critical drivers of long-term outperformance. Equally important, in our judgment, is to have a distinctive investment process built on robust cross-discipline collaboration. Leveraging insights from our global industry analysts and equity research teams, we strive for early identification of market inflections and price disconnects across sectors, including technology, financials, industrials, health care, energy, and consumer products.
To a large degree, “megatrends” undergird our investment convictions — longer-term trends and themes that we believe are going to structurally alter global market dynamics, asset pricing, and ingredients for 21st-century corporate success. Many high-quality, secular growth companies appear poised to benefit from one or more of these megatrends. Here are three areas where we see opportunities in companies that may be relatively well positioned to weather the risk of an economic slowdown over the next 12 months and beyond.
There is virtually no sector of the global economy that is immune from climate-related disruption. And as climate change intensifies across the globe, efforts to adapt to and mitigate the myriad consequences will only accelerate. While the so-called “energy transition” is beginning to dominate public climate discourse and also the flow of investors’ climate dollars, the path to a world of “net-zero” carbon emissions will require game-changing economic and corporate transformation of the sort not seen since the industrial revolution. Given the diversity and complexity of the challenge, markets are likely to miscalculate both the risks and the opportunities, potentially leading to exploitable asset price disconnects. Environmental, social, and governance (ESG) integration strategies can be a powerful way for equity investors to do just that.
Investment play: Silicon carbide in the electronification of autos
ESG investing and integration can of course take multiple forms, even within a particular sector. In global technology, we are most excited about the growing need for better, more reliable power management and, specifically, the evolution in power management semiconductors — an essential component in electric vehicles (EVs). An uptick in EV sales is becoming more evident worldwide, although the rate of adoption varies sharply by region and country. For example, many European nations have dramatically outpaced their global counterparts, including the US, which does not even crack the top-15 list (Figure 1).
Materials science advancements over the past decade have propelled the development of a new generation of silicon carbide-based semiconductors that can enable continued efficiency gains for EV makers. As these gains take hold in the years ahead, we anticipate further cost reductions in the manufacture of EV systems, likely improving affordability for car buyers and thereby helping to fuel the trend of increased EV adoption. Working off a dual theme of decarbonization and digitization, we expect this to be a big upcoming inflection point in global consumer demand for these more environmentally friendly vehicles.
While global digitization has been a durable megatrend for roughly the past two decades, we believe it still has much further to go. The volume of enterprise data produced is growing by around 40% annually, and the convergence of key enabling technologies — the cloud and robotics, artificial intelligence (AI) and machine learning (ML), the Internet of Things, fifth-generation (5G) technology — is likely to be a potent catalyst for how this thematic story continues to unfold in the period ahead. Enterprises are in a strategic “arms race” of sorts to aggregate data and integrate the software necessary to reap efficiencies from that data. How well companies execute on that will determine the winners and losers across sectors for the next decade or more.
Investment play: Software as a service/New cloud-based databases
With the 2021 – 2022 correction in many next-generation software-as-a-service (SaaS) stocks, we identified several new investment ideas. One area we find attractive, especially amid the unrelenting march of ever-more data creation around the world, is the continued growth of data and the need to manage it more effectively. Many providers of next-generation database management tools and services stand to benefit mightily from this trend, much of which comes down to the “cloud” — servers that are accessed over the internet, along with the software and databases that run on those servers.
Public-cloud expenditures as a percentage of total IT spending have risen significantly across every sector as enterprises seek third-party solutions for organizing and extracting insights from data. In fact, worldwide public-cloud services end-user spending could reach nearly US$600 billion by the end of 2023 (Figure 2). The proliferation of public and private clouds has spawned a need to transfer the data and databases associated with traditional workloads to a similar architecture. With fully cloud-architected database vendors emerging, we see a multi-decade market share opportunity for these new players. This is one of our highest-conviction investment ideas going into 2023.
In recent decades, an array of medical breakthroughs and refinements, together with generally healthier lifestyles across much of the world, have boosted average human life expectancies into the 70s and even 80s in some countries. This has fundamentally reshaped the global demographics picture: With people living longer than ever before, the share of the world population aged 65 years or older increased from 6% in 1990 to 9% in 2019. That proportion is projected to climb further to 16% by 2050, such that approximately one in six individuals may be senior citizens at midcentury. Moreover, while the entire globe will age rapidly over the next three decades, the developed world is doing so at a much faster pace than emerging markets (Figure 3).
Investment play: Genome sequencing technology to optimize health care
The potential implications of this seismic demographic shift are profound and far-reaching across sectors and industries, no more so than in the health care space. For example, how much might global demand for health care technology and services spike by 2050? By 2080? The answer to this and other questions will play a pivotal role in long-term return outcomes within different health care subsectors. For investors, deep research will be central to recognizing early on and capitalizing on the various manifestations of changing global demographics.
One pocket of investable opportunity within modern health care, which overlaps with the tech theme of digitization, lies in the onset of the next generation of genome sequencing equipment. (Broadly speaking, “genome sequencing” involves establishing the entire genetic makeup of an organism or cell type.) There is now stepped-up focus on reducing the cost to sequence the genome, allowing for major new modalities in preventing, diagnosing, and treating many chronic illnesses, such as heart disease. We believe approaching platform releases by existing leaders in sequencing technology, in addition to advancements by next-generation companies, should help drive strong future performance from the life sciences subsector of health care.
Experts
READ NEXT
Article 2
Stay up to date with the latest market insights and our point of view.
2024 Insurance Outlook: Position portfolios for the unexpected
Tim Antonelli offers two critical ideas for insurers' 2024 investment planning: doubling down on diversification and rethinking risk, including geopolitical and default risk.
Trends and transformation: Ideas for 2024
Explore our latest views on risks and opportunities across the global capital markets as we look ahead @to 2024
Beyond China: what does the rest of the EM equity world have to offer?
For investors contemplating a separate allocation to EM ex-China equities, members of our iStrat Team share their research on the composition of the opportunity set, the growing divergence in the behavior of EM ex-China equities and Chinese equities, and the long-term market outlook.
Monthly Market Snapshot – October 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Investing at the biopharma frontier
Rebecca Sykes details groundbreaking innovations happening today in the biopharmaceutical industry. She explains key advancements and the investment landscape for therapies targeting diabetes, cancer, and Alzheimer's disease, three of the deadliest and most expensive diseases facing the world today.
Monthly Market Snapshot – September 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Novel therapies changing the course of health care
Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.
Thematic investing focus: a new era for medical innovation
Advances in science, tools and technologies are transforming the face of healthcare, revolutionising the diagnosis and treatment of complex diseases. How can thematic investors identify promising opportunities?
Financial Market Review: Third quarter 2023
A monthly update on equity, fixed income, currency, and commodity markets.
Could being boring pay dividends for equity income investing?
Can being boring be a good thing? Our expert explains why he believes for equity income investors, it can be.
URL References
Related Insights
Look below the surface: A contrarian view on China equities
Equity expert, Ben Chen, dives into China's murky investment landscape.
By
Ben Chen